Ex Parte Auer et al - Page 2


                  Appeal No.  2004-2079                                                           Page 2                   
                  Application No.  09/754,958                                                                              
                         Claim 17 is illustrative of the subject matter on appeal and is reproduced                        
                  below:                                                                                                   
                         17. Compounds comprising structure of formula II or of formula III                                
                                                   A-B-D-C-D'-  (Formula  II)                                              
                                                A-B-D-  and  -D'-C (Formula III)                                           
                              wherein                                                                                      
                              A is selected from the group consisting of functionalized polystyrene                        
                              based resins, polyacrylamide based polymers, polystyrene/                                    
                              polydimethylacrylamide composites, PEGA resins, polystyrene-                                 
                              polyoxyethylene based supports, polystyrene/divinylbenzene-PEG                               
                              graft copolymers, PEG-polystyrene graft polymeric supports, glass                            
                              surfaces, functionalized surfaces, materials grafted with                                    
                              functionalized surfaces, and polyethylenglycol;                                              
                              B is a linker allowing cleavage of fluorescent conjugates of formula II                      
                              or of formula-III for liberation of the D and C containing fragments;                        
                              C is a compound selected from formula (I)                                                    






                                                                                               (I)                        
                              wherein                                                                                      
                              one of the radicals R1 or R2 and one of the radicals R3 or R4 is                             
                              hydrogen and the other is independently -COOH, -COOR7, -CONH2,                               
                              -CONH(CH2)nOH, -CONR8R9, -CH2OH, -CH2NH2, -NO2, NR10R11,                                     
                              NHCOR12, Cl, Br, F, -CF3, -N=C=O, -N=C=S,  -SO3H,                                            
                              -SO2NH(CH2)nNH2, (C1-C4)alkyl, (C1-C16)-alkyl substituted at the                             
                              terminal carbon with -COOH, -COOR7, -CONH2, -CONR8R9,                                        
                              -CONH(CH2)nOH, -CH2OH, -CH2NH2, -N=C=O, -N=C=S, -SO3H,                                       
                              -SO2NH(CH2)nNH2, -CONH(CH2)nNH2, and the -NH2 group could also                               
                              be substituted by (C1-C4) alkyl or a commonly used amino protecting                          
                              group;                                                                                       
                              and one of the radicals R5 or R6 is hydrogen and the other is                                
                              hydrogen, halogen, -NO2, -NR10R11, -NHCOR12, (C1-C4) alkyl, (C1-                             
                              C16)-alkyl substituted at the terminal carbon with -COOH,                                    





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007